Literature DB >> 17879316

Similarities and differences of human and experimental mouse lymphangiomas.

Philipp Kasten1, Gerrit Schnöink, Astrid Bergmann, Maria Papoutsi, Kerstin Buttler, Jochen Rössler, Herbert A Weich, Jörg Wilting.   

Abstract

Lymphangioma is a disfiguring malformation of early childhood. A mouse lymphangioma model has been established by injecting Freund's incomplete adjuvant (FIA) intraperitoneally, but has not been compared with the human disease. We show that, in accordance with studies from the 1960s, the mouse model represents an oil-granuloma, made up of CD45-positive leukocytes and invaded by blood and lymph vessels. Several markers of lymphatic endothelial cells are expressed in both mouse and human, like CD31, Prox1, podoplanin, and Lyve-1. However, the human disease affects all parts of the lymphovascular tree. We observed convolutes of lymphatic capillaries, irregularly formed collectors with signs of disintegration, and large lymph cysts. We observed VEGFR-2 and -3 expression in both blood vessels and lymphatics of the patients, whereas in mouse VEGFR-2 was confined to activated blood vessels. The experimental mouse FIA model represents a vascularized oil-granuloma rather than a lymphangioma and reflects the complexity of human lymphangioma only partially. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17879316     DOI: 10.1002/dvdy.21298

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  7 in total

1.  Mouse lung contains endothelial progenitors with high capacity to form blood and lymphatic vessels.

Authors:  Judith Schniedermann; Moritz Rennecke; Kerstin Buttler; Georg Richter; Anna-Maria Städtler; Susanne Norgall; Muhammad Badar; Bernhard Barleon; Tobias May; Jörg Wilting; Herbert A Weich
Journal:  BMC Cell Biol       Date:  2010-07-01       Impact factor: 4.241

2.  VEGF-C and VEGFR-3 in a series of lymphangiomas: is superficial lymphangioma a true lymphangioma?

Authors:  Eijun Itakura; Hidetaka Yamamoto; Yoshinao Oda; Masutaka Furue; Masazumi Tsuneyoshi
Journal:  Virchows Arch       Date:  2009-01-17       Impact factor: 4.064

3.  Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children.

Authors:  Hugo de Oliveira Olímpio; Joaquim Bustorff-Silva; Antonio Gonçalves de Oliveira Filho; Kleber Cursino de Araujo
Journal:  Clinics (Sao Paulo)       Date:  2014-08       Impact factor: 2.365

4.  Morphological and Molecular Characterization of Human Dermal Lymphatic Collectors.

Authors:  Viktoria Hasselhof; Anastasia Sperling; Kerstin Buttler; Philipp Ströbel; Jürgen Becker; Thiha Aung; Gunther Felmerer; Jörg Wilting
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

5.  Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium.

Authors:  Maria Cimini; Antonio Cannatá; Gianandrea Pasquinelli; Marcello Rota; Polina Goichberg
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

6.  PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations.

Authors:  Hannah Blesinger; Silke Kaulfuß; Thiha Aung; Sonja Schwoch; Lukas Prantl; Jochen Rößler; Jörg Wilting; Jürgen Becker
Journal:  PLoS One       Date:  2018-07-09       Impact factor: 3.240

7.  Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis.

Authors:  Scott C Johns; Xin Yin; Michael Jeltsch; Joseph R Bishop; Manuela Schuksz; Roland El Ghazal; Sarah A Wilcox-Adelman; Kari Alitalo; Mark M Fuster
Journal:  Circ Res       Date:  2016-05-25       Impact factor: 17.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.